Connection

Girish Nadkarni to Trimetazidine

This is a "connection" page, showing publications Girish Nadkarni has written about Trimetazidine.
Connection Strength

0.609
  1. Trimetazidine Decreases Risk of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Pharmacol Ther. 2015 Nov; 20(6):539-46.
    View in: PubMed
    Score: 0.609
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.